手动復苏器市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024年，全球手动復苏器市场规模达5.324亿美元，预计2034年将以6.5%的复合年增长率成长，达到9.899亿美元。呼吸系统疾病的增加、手术量的增加以及产品的持续改进，都大大促进了该市场的扩张。这些復苏工具通常被称为手动正压通气（PPV）设备，对于在关键时刻（无论是手术、急救还是重症监护）提供正压通气至关重要。随着呼吸系统疾病和心臟骤停的负担日益加重，医院内外对便携式高效能手动復苏器的需求都在增加。

如今，先进的设计包括安全阀、抗菌材料以及用户友好的功能，可为训练有素的医疗专业人员和非专业急救人员提供支援。这种对易用性和可靠性的关注，正在推动其在高压环境下的应用，因为在这些环境下，快速、精准的干预至关重要。此外，支持可重复使用和耐灭菌的研发成果正在提升医护人员的价值和长期实用性。随着医疗保健系统持续为不可预测的紧急情况和公共卫生威胁做好准备，可靠的復苏解决方案的重要性仍然不容忽视。

2024年，自充气式復苏器市场规模达2.465亿美元。这类復苏器因其操作简便、无需外部氧源即可工作而备受青睐，从而提升了其在快速紧急情况下的机动性和有效性。在缺乏稳定医疗基础设施的环境中，自充气式復苏器的应用显着提升了其市场份额。由于其可靠性，自充气式復苏器在创伤、心肺復苏术和重大医疗事件中仍然是首选。它们在不可预测的条件下一致的表现增强了市场需求，尤其是在急诊、救护车和救灾行动中，这些场合需要立即且大量地提供可靠的呼吸支援。

一次性復苏器市场在2024年达到3.004亿美元，预计到2034年将以6.8%的复合年增长率成长。随着医疗系统加强感染控制规程，一次性復苏器因其一次性使用的特性，降低了交叉污染的风险，其受欢迎程度急剧上升。这些復苏器无需消毒，重量轻，操作简便，非常适合救护车、野战医院和疫情应变小组等时间紧迫的场合。在公共卫生紧急事件、大规模伤亡事件和军事行动中，它们的作用尤其重要，因为在这些情况下，卫生、准备就绪和快速部署至关重要。这些特性使其成为大规模紧急准备策略中值得信赖的资产。

美国手动復苏器市场在2024年创收1.876亿美元，预计2025年至2034年间的复合年增长率将达到5.9%。该地区的成长主要源于呼吸系统疾病和心臟病急症病例的增加。美国拥有世界上最先进的医疗保健体系之一，并广泛应用高阶復苏器技术。公共和私营机构对急救护理和新生儿设施的大量投资持续刺激了需求。美国致力于最大限度地减少医院内感染，这进一步推动了一次性产品的日益普及。包括限压阀和先进的生物相容性材料等技术进步，持续提升了产品的安全性和功能性。

全球手动復苏器市场的知名企业包括 Teleflex、AirLife、ROMSONS、Besmed、Laerdal、GALEMED、Fisher & Paykel Healthcare、FLEXICARE、MercuryMedical、HSINER、ASIA CONNECTION、Angiplast、Medline、BOENMED、Neokraft 和 Classic Plastics。为巩固市场地位，手动復苏器产业的企业正专注于创新、产品多功能性和法规遵循。许多公司正在透过压力控制系统、抗菌组件和人体工学设计来增强其产品线，以支援在关键环境中的快速部署和易用性。全球企业正增加一次性产品的投资，以符合感染控制重点。与紧急医疗服务和医院建立策略伙伴关係有助于提高市场渗透率，而向新兴市场的地理扩张则增强了分销能力。企业也正在利用先进的製造技术来降低成本并提高产品品质。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
  • 供应商格局
  • 每个阶段的增值
  • 影响价值链的因素
• 产业衝击力
  • 成长动力
    • 呼吸系统疾病发生率不断上升
    • 復苏设备的技术进步
    • 外科手术增多
  • 产业陷阱与挑战
    • 使用不当或过度换气的风险
  • 市场机会
• 成长潜力分析
• 监管格局
• 技术和创新格局
  • 当前的技术趋势
  • 新兴技术
• 报销场景
  • 报销政策对市场成长的影响
• 波特的分析
• PESTEL分析
• 差距分析
• 未来市场趋势
• 价值链分析

第四章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
  • 按地区
    • 北美洲
    • 欧洲
    • 亚太地区
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 关键进展
  • 併购
  • 伙伴关係和合作
  • 新产品发布
  • 扩张计划

第五章：市场估计与预测：依产品类型，2021 - 2034 年

• 主要趋势
• 自充气復苏器
• 流量充气復苏器
• T 型件

第六章：市场估计与预测：按方式，2021 - 2034 年

• 主要趋势
• 一次性的
• 可重复使用的

第七章：市场估计与预测：按材料，2021 - 2034 年

• 主要趋势
• 硅酮
• PVC
• 橡皮

第八章：市场估计与预测：依病患类型，2021 - 2034 年

• 主要趋势
• 成人
• 儿科
• 新生儿

第九章：市场估计与预测：按应用，2021 - 2034 年

• 主要趋势
• 慢性阻塞性肺臟疾病
• 心肺骤停
• 其他应用

第 10 章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 门诊手术中心
• 其他最终用途

第 11 章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十二章：公司简介

• ANGIPLAST
• AirLife
• ASIA CONNECTION
• Besmed
• BOENMED
• Fisher & Paykel HEALTHCARE
• Flexicare
• GaleMed
• HSINER
• Laerdal
• MEDLINE
• MercuryMedical
• NEOKRAFT
• Romsons
• Teleflex

The Global Manual Resuscitators Market was valued at USD 532.4 million in 2024 and is estimated to grow at a CAGR of 6.5% to reach USD 989.9 million by 2034. A rising number of respiratory ailments, increasing surgical volumes, and continuous product enhancements are contributing significantly to this market's expansion. These resuscitation tools, often referred to as hand-operated PPV devices, are essential for delivering positive pressure ventilation in critical moments-whether during surgery, emergencies, or intensive care. With the rising burden of respiratory conditions and cardiac arrests, the demand for portable, effective manual resuscitators is growing both inside and outside hospital environments.

Advanced designs now include safety valves, antimicrobial materials, and user-friendly features that support both trained medical professionals and non-specialist responders. This focus on ease of use and reliability is boosting adoption in high-pressure settings where quick, precise intervention is essential. Additionally, developments that support reusability and withstand sterilization are increasing value and long-term utility for care providers. As healthcare systems continue to prepare for unpredictable emergencies and public health threats, the importance of dependable resuscitation solutions remains robust.

In 2024, the self-inflating resuscitators segment generated USD 246.5 million. These resuscitators are favored for their ease of operation and the ability to function independently of external oxygen sources, which enhances mobility and effectiveness in fast-paced emergency scenarios. Their utility in environments without stable medical infrastructure has significantly strengthened their market share. These devices continue to be the top choice during trauma, CPR, and critical medical events due to their reliability. Their consistent performance in unpredictable conditions reinforces demand, particularly in emergency departments, ambulances, and disaster relief operations where dependable respiratory support is required immediately and in large volumes.

The disposable resuscitator segment recorded USD 300.4 million in 2024 and is forecasted to grow at a CAGR of 6.8% through 2034. As healthcare systems tighten infection control protocols, disposable options are seeing a sharp rise in preference due to their single-use nature, which reduces cross-contamination risks. These resuscitators eliminate the need for sterilization, are lightweight, easy to operate, and perfectly suited for time-critical settings like ambulances, field hospitals, and pandemic response teams. Their role becomes even more vital during public health emergencies, mass casualty events, and military operations, where hygiene, readiness, and rapid deployment are crucial. These characteristics make them a dependable asset in large-scale emergency preparedness strategies.

U.S. Manual Resuscitators Market generated USD 187.6 million in 2024 and is expected to grow at a CAGR of 5.9% between 2025 and 2034. Growth in this region is driven by rising cases of respiratory conditions and cardiac emergencies. The U.S. benefits from having one of the world's most advanced healthcare systems, with widespread use of premium resuscitator technologies. Substantial investments in emergency care and neonatal facilities by both public and private entities continue to boost demand. An increasing shift toward disposable products is further supported by the country's focus on minimizing hospital-acquired infections. Technological progress, including features like pressure-limiting valves and advanced, biocompatible materials, continues to elevate product safety and functionality.

Notable players in the Global Manual Resuscitators Market include Teleflex, AirLife, ROMSONS, Besmed, Laerdal, GALEMED, Fisher & Paykel Healthcare, FLEXICARE, MercuryMedical, HSINER, ASIA CONNECTION, Angiplast, Medline, BOENMED, Neokraft, and Classic Plastics. To reinforce their market position, companies in the manual resuscitators industry are focusing on innovation, product versatility, and regulatory compliance. Many firms are enhancing their product lines with pressure-control systems, antimicrobial components, and ergonomic designs to support rapid deployment and ease of use in critical settings. Global players are increasingly investing in disposable variants to align with infection control priorities. Strategic partnerships with emergency medical services and hospitals help improve market penetration, while geographic expansion into emerging markets boosts distribution capabilities. Companies are also leveraging advanced manufacturing technologies to reduce costs and enhance product quality.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product type
  • 2.2.3 Modality
  • 2.2.4 Material
  • 2.2.5 Patient type
  • 2.2.6 Application
  • 2.2.7 End use
• 2.3 CXO perspectives: strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Value addition at each stage
  • 3.1.3 Factors affecting the value chain
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing incidence of respiratory disorders
    • 3.2.1.2 Technological advancements in resuscitation devices
    • 3.2.1.3 Rising surgical procedures
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Risk of improper use or hyperventilation
  • 3.2.3 Market opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Reimbursement scenario
  • 3.6.1 Impact of reimbursement policies on market growth
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Gap analysis
• 3.10 Future market trends
• 3.11 Value chain analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 By region
    • 4.3.1.1 North America
    • 4.3.1.2 Europe
    • 4.3.1.3 Asia Pacific
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Self-inflating resuscitators
• 5.3 Flow-inflating resuscitators
• 5.4 T-piece

Chapter 6 Market Estimates and Forecast, By Modality, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Disposable
• 6.3 Reusable

Chapter 7 Market Estimates and Forecast, By Material, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Silicone
• 7.3 PVC
• 7.4 Rubber

Chapter 8 Market Estimates and Forecast, By Patient type, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Adult
• 8.3 Pediatric
• 8.4 Neonatal

Chapter 9 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Chronic obstructive pulmonary disease
• 9.3 Cardiopulmonary arrest
• 9.4 Other applications

Chapter 10 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 Hospitals
• 10.3 Ambulatory surgical centers
• 10.4 Other end use

Chapter 11 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 11.1 Key trends
• 11.2 North America
  • 11.2.1 U.S.
  • 11.2.2 Canada
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 France
  • 11.3.4 Spain
  • 11.3.5 Italy
  • 11.3.6 Netherlands
• 11.4 Asia Pacific
  • 11.4.1 China
  • 11.4.2 Japan
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 South Korea
• 11.5 Latin America
  • 11.5.1 Brazil
  • 11.5.2 Mexico
  • 11.5.3 Argentina
• 11.6 Middle East and Africa
  • 11.6.1 South Africa
  • 11.6.2 Saudi Arabia
  • 11.6.3 UAE

Chapter 12 Company Profiles

• 12.1 ANGIPLAST
• 12.2 AirLife
• 12.3 ASIA CONNECTION
• 12.4 Besmed
• 12.5 BOENMED
• 12.6 Fisher & Paykel HEALTHCARE
• 12.7 Flexicare
• 12.8 GaleMed
• 12.9 HSINER
• 12.10 Laerdal
• 12.11 MEDLINE
• 12.12 MercuryMedical
• 12.13 NEOKRAFT
• 12.14 Romsons
• 12.15 Teleflex